Breaking News Instant updates and real-time market news.

CLVS

Clovis

$34.76

-0.59 (-1.67%)

10:13
10/05/16
10/05
10:13
10/05/16
10:13

Clovis early strength attributed to renewed takeover speculation

Shares of Clovis Oncology (N) have built upside momentum in early trading, with market participants attributing the strength to renewed takeover speculation, according to trading contacts. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly's news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved. Shares of Clovis have rallied about 3% to $35.79 in early trading.

  • 06

    Nov

  • 23

    Feb

CLVS Clovis
$34.76

-0.59 (-1.67%)

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
JANY
09/21/16
DOWNGRADE
JANY
Neutral
Clovis downgraded to Neutral from Buy at Janney Capital
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).
10/04/16
PIPR
10/04/16
NO CHANGE
Target $42
PIPR
Neutral
Clovis price target raised to $42 from $14 at Piper Jaffray
Piper Jaffray analyst Steven Breazzano raised his price target for Clovis Oncology (CLVS) to $42 after taking a "comprehensive look" at the PARP inhibitor landscape in ovarian cancer and beyond. The company's PARP inhibitor rucaparib has demonstrated an active profile in ovarian cancer and all signs point to an approval in the 3L+ setting early next year, Breazzano tells investors in a research note. The analyst, however, believes the ultimate key is success in the earlier maintenance setting, and he thinks the race may still be Tesaro's (TSRO) niraparib's to lose. Breazzano keeps a Neutral rating on Clovis.

TODAY'S FREE FLY STORIES

BGSF

BG Staffing

$15.15

-0.27 (-1.75%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Earnings
BG Staffing reports Q1 EPS 15c, consensus 12c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

TMO

Thermo Fisher

$168.01

9.2 (5.79%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 06

    Jun

SNBC

Sun Bancorp

$25.70

-0.05 (-0.19%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Earnings
Sun Bancorp reports Q1 EPS 7c, consensus 8c »

Reports Q1 NII $14.78M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 15

    May

UPS

UPS

$107.62

0.26 (0.24%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Hot Stocks
UPS says sees margin improvement in 2017 »

Expects revenue to grow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

RTN

Raytheon

$155.27

-0.74 (-0.47%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Hot Stocks
Raytheon raises FY17 EPS view to $7.25-$7.40 from $7.20-$7.35, consensus $7.40 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

BA

Boeing

$181.71

-1.8 (-0.98%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Recommendations
Exact Sciences analyst commentary  »

Exact Sciences Q1 report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

AA

Alcoa

$36.45

-0.04 (-0.11%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Syndicate
Alcoa 12.959M share Spot Secondary priced at $36.15 »

Citi and Credit Suisse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

X

U.S. Steel

$22.78

-8.33 (-26.78%)

, NSC

Norfolk Southern

$117.82

1.04 (0.89%)

08:56
04/27/17
04/27
08:56
04/27/17
08:56
Options
Notable open interest changes for April 27th »

Wednesday's total…

X

U.S. Steel

$22.78

-8.33 (-26.78%)

NSC

Norfolk Southern

$117.82

1.04 (0.89%)

BAC

Bank of America

$23.89

-0.09 (-0.38%)

TWTR

Twitter

$15.82

1.16 (7.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 11

    May

  • 31

    May

  • 06

    Jun

CTB

Cooper Tire

$43.40

0.05 (0.12%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Technical Analysis
Cooper Tire drops sharply after earnings miss »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 18

    May

AAL

American Airlines

$46.40

-0.21 (-0.45%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Hot Stocks
American Airlines sees positive revenue improvements in each quarter of 2017 »

American Airlines CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

UTHR

United Therapeutics

$119.99

-1.75 (-1.44%)

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Recommendations
United Therapeutics analyst commentary  »

United Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

08:55
04/27/17
04/27
08:55
04/27/17
08:55
General news
The 14k initial claims pop to 257k »

The 14k initial claims…

08:55
04/27/17
04/27
08:55
04/27/17
08:55
Conference/Events
FDIC to hold a committee meeting »

The Committee on Economic…

DXCM

Dexcom

$75.68

0.74 (0.99%)

08:54
04/27/17
04/27
08:54
04/27/17
08:54
Initiation
Dexcom initiated  »

Dexcom assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BRKL

Brookline Bancorp

$15.95

0.35 (2.24%)

08:54
04/27/17
04/27
08:54
04/27/17
08:54
Syndicate
Brookline Bancorp 4.8M share Spot Secondary priced at $14.50 »

Piper Jaffray acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

BRKL

Brookline Bancorp

$15.95

0.35 (2.24%)

08:54
04/27/17
04/27
08:54
04/27/17
08:54
Syndicate
Brookline Bancorp 4.8M share Spot Secondary priced at $14.50 »

Piper Jaffray acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

08:53
04/27/17
04/27
08:53
04/27/17
08:53
General news
Futures slightly higher as investors digest torrent of earnings »

Stock futures are…

MGP

MGM Growth

$28.20

0.22 (0.79%)

08:53
04/27/17
04/27
08:53
04/27/17
08:53
Earnings
MGM Growth reports Q1 EPS 20c, consensus 22c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

MEP

Midcoast Energy

$7.95

-0.05 (-0.63%)

08:52
04/27/17
04/27
08:52
04/27/17
08:52
Hot Stocks
Breaking Hot Stocks news story on Midcoast Energy »

Midcoast Energy trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$18.14

0.17 (0.95%)

, UAA

Under Armour

$19.71

0.18 (0.92%)

08:52
04/27/17
04/27
08:52
04/27/17
08:52
Hot Stocks
Under Armour CEO says 'working through' Curry shoe inventory imbalance »

Under Armour CEO Kevin…

UA

Under Armour

$18.14

0.17 (0.95%)

UAA

Under Armour

$19.71

0.18 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

WCN

Waste Connections

$89.51

-0.74 (-0.82%)

08:52
04/27/17
04/27
08:52
04/27/17
08:52
Earnings
Waste Connections sees Q2 revenue $1.145B-$1.15B, consensus $1.13B »

Guidance provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 15

    Jun

  • 20

    Jun

SMI

SMIC

$5.93

0.03 (0.51%)

, TSM

TSMC

$33.00

-0.07 (-0.21%)

08:52
04/27/17
04/27
08:52
04/27/17
08:52
Periodicals
SMIC reportedly hires former TSMC R&D executive Liang, DigiTimes says »

Semiconductor…

SMI

SMIC

$5.93

0.03 (0.51%)

TSM

TSMC

$33.00

-0.07 (-0.21%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$11.60

0.12 (1.05%)

08:51
04/27/17
04/27
08:51
04/27/17
08:51
Hot Stocks
Ford sees total company adjusted PBT to improve for 2018 »

Still expects automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

ACHC

Acadia

$42.19

-1.39 (-3.19%)

08:50
04/27/17
04/27
08:50
04/27/17
08:50
Recommendations
Acadia analyst commentary  »

Acadia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.